Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Piltonen, T. (Terhi)"'
Autor:
Piltonen, T. (Terhi)
The number of ovarian follicles declines with age resulting in a significant decrease of fertility by the age of 40. However, the age when follicle loss starts to affect ovarian endocrine function is not well recognized. The purpose of the present st
Externí odkaz:
http://urn.fi/urn:isbn:9514274369
Autor:
Joham, A. E. (Anju E.), Piltonen, T. (Terhi), Lujan, M. E. (Marla E.), Kiconco, S. (Sylvia), Tay, C. T. (Chau Thien)
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting 8%–13% of reproductive‐aged women. The aetiology of the syndrome is complex, with genetic susceptibility, androgen exposure in early life and adiposity related dysfuncti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::645e1cf3d178a97c7b4a25235a1dc4e4
http://urn.fi/urn:nbn:fi-fe2022092760252
http://urn.fi/urn:nbn:fi-fe2022092760252
Autor:
Chen, M. J. (Melissa J.), Jensen, J. T. (Jeffrey T.), Kaunitz, A. M. (Andrew M.), Achilles, S. L. (Sharon L.), Zatik, J. (János), Weyers, S. (Steven), Piltonen, T. (Terhi), Suturina, L. (Larisa), Apolikhina, I. (Inna), Bouchard, C. (Celine), Archer, D. F. (David F.), Jost, M. (Maud), Foidart, J.-M. (Jean-Michel), Creinin, M. (Mitchell)
Objectives: To evaluate tolerability and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg oral contraceptive using pooled data from two, multicenter, phase 3 trials. Study design: The two trials enrolled participants aged 16−50 years with a b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::ba4c1b9d8d44f5b74b5715726ba6c717
http://urn.fi/urn:nbn:fi-fe2023052447571
http://urn.fi/urn:nbn:fi-fe2023052447571
Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine disorders in women and despite this, diagnostic challenges, delayed diagnosis, and less-than-optimal treatment regimens plague the condition. The International PCOS net
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::58123b3635b8baef65541fcbd5ce8eb8
http://urn.fi/urn:nbn:fi-fe202201178808
http://urn.fi/urn:nbn:fi-fe202201178808
Autor:
West, S. (Sammeli), Ollila, M. (Meri‐Maija), Franks, S. (Stephen), Piltonen, T. (Terhi), Jokelainen, J. (Jari), Nevalainen, J. (Jaana), Puukka, K. (Katri), Ruokonen, A. (Aimo), Järvelin, M. (Marjo‐Riitta), Auvinen, J. (Juha), Tapanainen, J. S. (Juha S.), Morin‐Papunen, L. (Laure)
Introduction: The aim of the study was to determine the association of body mass index (BMI), self‐reported symptoms or diagnosis of polycystic ovary syndrome (PCOS), and hyperandrogenemia with the occurrence of gestational diabetes mellitus (GDM)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::d387477b24ec5ac7ef7b146984495aa9
http://urn.fi/urn:nbn:fi-fe2020101584129
http://urn.fi/urn:nbn:fi-fe2020101584129
Autor:
Mosorin, M.-E. (Maria-Elina), Haverinen, A. (Annina), Ollila, M.-M. (Meri-Maija), Nordström, T. (Tanja), Jokelainen, J. (Jari), Keinänen-Kiukaanniemi, S. (Sirkka), Puukka, K. (Katri), Ruokonen, A. (Aimo), Auvinen, J. (Juha), Piltonen, T. (Terhi), Morin-Papunen, L. (Laure), Tapanainen, J. S. (Juha S)
Objective: The use of combined hormonal contraceptives (CHCs) worsens glucose tolerance, but the risk for glucose metabolism disorders remains controversial. Design: The study is a prospective longitudinal population-based cohort study. Methods: The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::81bfb9feea81d13595c59ed9842f1aa7
http://urn.fi/urn:nbn:fi-fe2022031623824
http://urn.fi/urn:nbn:fi-fe2022031623824
Autor:
Ollila, M.-M. (Meri-Maija), Kiviniemi, A. (Antti), Stener-Victorin, E. (Elisabet), Tulppo, M. (Mikko), Puukka, K. (Katri), Tapanainen, J. (Juha), Franks, S. (Stephen), Morin-Papunen, L. (Laure), Piltonen, T. (Terhi)
Objectives: Previous studies of women in their 20s and 30s have reported impaired autonomic function in women with polycystic ovary syndrome (PCOS). We aimed to study, for the first time, whether PCOS is associated with impaired cardiac autonomic fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::024e74c7a8928fbd876e4205a84ccc89
http://urn.fi/urn:nbn:fi-fe2020042822739
http://urn.fi/urn:nbn:fi-fe2020042822739
Autor:
Khomami, M. B. (Mahnaz Bahri), Joham, A. E. (Anju E.), Boyle, J. A. (Jacqueline A.), Piltonen, T. (Terhi), Silagy, M. (Michael), Arora, C. (Chavy), Misso, M. L. (Marie L.), Teede, H. J. (Helena J.), Moran, L. J. (Lisa J.)
Polycystic ovary syndrome (PCOS) is associated with an increased risk of maternal pregnancy and delivery complications. However, the impact of clinical features of PCOS and other potential risk factors in PCOS is still unknown. We aimed to investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::ccf17a59ef6395b529fa88fe653d46d4
http://urn.fi/urn:nbn:fi-fe2020091769941
http://urn.fi/urn:nbn:fi-fe2020091769941
Autor:
Khomami, M. B. (Mahnaz Bahri), Joham, A. E. (Anju E.), Boyle, J. A. (Jacqueline A.), Piltonen, T. (Terhi), Arora, C. (Chavy), Silagy, M. (Michael), Misso, M. L. (Marie L.), Teede, H. J. (Helena J.), Moran, L. J. (Lisa J.)
Polycystic ovary syndrome (PCOS) is associated with worsened pregnancy and infant outcomes, higher body mass index (BMI), and longitudinal weight gain. Despite most of the clinical features of PCOS being risk factors for worsened infant outcomes in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::8fd03d858f3891efefb2b0d67d84d2a6
http://urn.fi/urn:nbn:fi-fe2020091669825
http://urn.fi/urn:nbn:fi-fe2020091669825
Autor:
Palaniswamy, S. (Saranya), Piltonen, T. (Terhi), Koiranen, M. (Markku), Mazej, D. (Darja), Järvelin, M.-R. (Marjo-Riitta), Abass, K. (Khaled), Rautio, A. (Arja), Sebert, S. (Sylvain)
Background: Copper is an abundant trace element in humans where alterations in the circulating concentration could inform on chronic disease aetiology. To date, data are lacking to study how copper may associate with cardiovascular disease (CVD) risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::ed272060289e9dcec618aa66259ea5da
http://urn.fi/urn:nbn:fi-fe2019051515673
http://urn.fi/urn:nbn:fi-fe2019051515673